Kyoungbo Pharmaceutical Co., Ltd.
Kyoungbo Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in South Korea under 3128104567, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Asan-si, South Korea. 5 shareholders are on record for Kyoungbo Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 30 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Kyoungbo Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS).
The largest of these is DFA Emerging Markets Core Equity Portfolio, holding 43.3% — the largest recorded stake — followed by Dimensional ETF Tr-Dimensional Emerging Core Equity Market ETF at 3.6%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 8 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| DFA Emerging Markets Core Equity Portfolio | 43.3% | Supreme Court Internet Registry (IROS) | |
| Dimensional ETF Tr-Dimensional Emerging Core Equity Market ETF | 3.6% | Supreme Court Internet Registry (IROS) | |
| Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF | 2.1% | Supreme Court Internet Registry (IROS) | |
| Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF | 1.9% | Supreme Court Internet Registry (IROS) | |
| DFA Emerging Markets ex China Core Equity Portfolio | 1.6% | Supreme Court Internet Registry (IROS) |
Officers
1
One officer is currently on record for Kyoungbo Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). Tae-young Kim serves as Chief Executive Officer.
Management authority at Kyoungbo Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Kyoungbo Pharmaceutical Co., Ltd.?
Five shareholders are currently on record for Kyoungbo Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). The largest of these is DFA Emerging Markets Core Equity Portfolio, holding 43.3% — the largest recorded stake — followed by Dimensional ETF Tr-Dimensional Emerging Core Equity Market ETF at 3.6%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Kyoungbo Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Kyoungbo Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Kyoungbo Pharmaceutical Co., Ltd. have on record?
5 shareholders are shown on record for Kyoungbo Pharmaceutical Co., Ltd.. The register reports 8 in total; only the top 5 by holding are shown here.
What is Kyoungbo Pharmaceutical Co., Ltd.'s company registration number?
Kyoungbo Pharmaceutical Co., Ltd.'s registration number is 3128104567, filed with Supreme Court Internet Registry (IROS) in South Korea. Its current status on the register is active.
Is Kyoungbo Pharmaceutical Co., Ltd. still an active company?
Kyoungbo Pharmaceutical Co., Ltd.'s status on Supreme Court Internet Registry (IROS) is listed as active.
What is Kyoungbo Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Kyoungbo Pharmaceutical Co., Ltd. is Asan-si, South Korea.
What legal structure is Kyoungbo Pharmaceutical Co., Ltd. registered as?
Kyoungbo Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Kyoungbo Pharmaceutical Co., Ltd.?
One officer is currently on record for Kyoungbo Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). Tae-young Kim serves as Chief Executive Officer. Management authority at Kyoungbo Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Kyoungbo Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Kyoungbo Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Kyoungbo Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Kyoungbo Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 30 September 2026.